Pharma

Researcher
By  Laura Lovett 02:05 pm February 18, 2022
Artificial intelligence could potentially disrupt nearly every industry. Pharma giants have continued to take note. From AI in drug discovery to digital therapeutics, big name life science companies have invested time and money into the space.  However, big tech's move fast and break things mentality doesn't always align with pharma's regulated model. Today a number of accelerators and labs are...
scientists
By  Dr. Liz Kwo 10:44 am February 11, 2022
Digital technologies have filtered into nearly every facet of medicine, from drug discovery all the way to consumer fitness. But digital health isn't the only relative newcomer that could disrupt the status quo in health. The precision genomics space is also growing in popularity and use. What is precision genomics, and how will this space work with digital health?  Precision genomics medicine...
Doctor talks to patient
By  Laura Lovett 03:04 pm February 8, 2022
YPrime, a cloud-based clinical trial data management tool, announced its plans to buy patient engagement tool Tryl for an undisclosed sum.  Tryl is focused on curbing clinical trial dropout rates by using machine learning and behavioral science to help engage patients and collect data. Patients are able to tap into personalized support throughout the clinical trial. The technology also includes a...
Doctor talks to patient
By  Laura Lovett 02:26 pm February 7, 2022
Retail giant CVS is teaming up with unicorn digital clinical trial company Medable on a new initiative to grow clinical trial engagement at the former's CVS MinuteClinics.  The new effort will be run by the recently launched CVS Health Clinical Trial Services, and use Medable's platform to help enroll patients and conduct clinical trials. The pair are pitching this program as a way to help boost...
A woman with cancer is consulting her doctor.
By  Emily Olsen 11:38 am February 7, 2022
Trialjectory, a startup that matches cancer patients to clinical trials, announced Monday it had raised $20 million in Series A funding. The round was led by Insight Partners, with participation from JAL Ventures, Contour Venture Partners, Rho Capital and TIA Ventures. WHAT IT DOES The company offers an AI-enabled platform where patients can input information about their type of cancer and...
By  Laura Lovett 11:07 am February 2, 2022
Digital clinical trial platform Medable has snapped up LEO Innovation Lab's dermatology-focused platform Omhu A/S for an undisclosed sum.  This news comes just months after Medable announced a whopping $304 million in Series D funding, which brought the company's total valuation to $2.1 billion.  Copenhagen, Denmark-based Omhu has several offerings, including an app called Imagine, which helps...
Person on the phone
By  Laura Lovett 03:07 pm January 31, 2022
Pharma giant Pfizer is setting its sights on the digital therapeutics space, inking a new strategic commercial partnership with Swedish startup Alex Therapeutics.  The joint effort will tap into Alex Therapeutics AI-based platform that integrates both cognitive behavioral therapy (CBT) and Acceptance and Commitment Therapy (ACT) with AI in order to personalize care. Initially the pair will focus...
Philips 12-lead ECG system
By  Laura Lovett 11:56 am January 26, 2022
Med tech giant Royal Philips is rolling out a new at-home ECG system for decentralized clinical trial use. The company is pitching this new technology as a way for clinical trial participants to record ECG data without traveling to a clinical site or requiring an in-home clinician.  Trial participants wear a PCA 500 ECG body patch with a 12-lead ECG, which can securely transmit data in "near real...
Doctor with smartphone
By  Laura Lovett 02:18 pm January 24, 2022
The digital therapeutics industry, encompassing prescription software that aim to treat specific conditions, is continuing to expand. Investors and healthcare stakeholders are beginning to take notice. In December, Pear Therapeutics became one of the first digital therapeutics companies to go public.  However, there are still many questions around the usability and scalability of these products....